Skip to content

Drug interactions

Cannabidiol + Sofosbuvir-velpatasvir-voxilaprevir

Severity: Minor

Cannabidiol and Sofosbuvir-velpatasvir-voxilaprevir: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cannabidiol can inhibit several CYP enzymes and may modestly raise exposure to velpatasvir and voxilaprevir. The expected clinical effect is small, but exposure to the antivirals could increase slightly.

What this interaction means in plain words

Cannabidiol and Sofosbuvir-velpatasvir-voxilaprevir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Cannabidiol belongs to Central Nervous System; Sofosbuvir-velpatasvir-voxilaprevir belongs to Anti Virals.

Evidence level: Low

Why it happens

Cannabidiol may inhibit CYP2C8 and other CYP enzymes involved in velpatasvir and voxilaprevir metabolism, a prediction that is largely theoretical.

What to do

No routine dose change is needed. Monitor for adverse effects of the antiviral combination such as headache, fatigue and gastrointestinal upset, and for liver enzyme changes in patients taking cannabidiol.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cannabidiol and Sofosbuvir-velpatasvir-voxilaprevir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Cannabidiol with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp rates the interaction as minor. Cannabidiol and Sofosbuvir-velpatasvir-voxilaprevir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Cannabidiol can inhibit several CYP enzymes and may modestly raise exposure to velpatasvir and voxilaprevir. The expected clinical effect is small, but exposure to the antivirals could increase slightly.

How serious is the interaction between Cannabidiol and Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed. Monitor for adverse effects of the antiviral combination such as headache, fatigue and gastrointestinal upset, and for liver enzyme changes in patients taking cannabidiol.

What other medicines interact with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp also lists interactions of Sofosbuvir-velpatasvir-voxilaprevir with, for example, Fosphenytoin, Phenobarbital, Phenytoin. The full list is on the Sofosbuvir-velpatasvir-voxilaprevir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in